Advanced Medical Solutions trading in line after first half

Surgical and advanced wound care specialist company Advanced Medical Solutions Group updated the market on its trading in the six months ended 30 June on Thursday.

The AIM-traded firm said it continued to make “good progress” across the group, and confirmed that trading was in line with the board's expectations.

“The board is pleased with the ongoing performance of the business and we remain on track for the full year,” said AMS chief executive officer Chris Meredith in a short statement.

“We continue to be focused on our strategic objectives to grow organically and through acquisition whilst delivering innovation from our research and development pipeline.”

The group said it expected to publish its interim results for the period on 12 September.